Subscribe to Newsletter

Discovery & Development

Discovery & Development Dosage Forms

Breaking the Mold Layer-by-Layer

| Atul Ashok Kumar Lohade | 6 min read

As 3D printing gains traction in the pharma industry, its potential to revolutionize solid oral dosage forms is becoming clearer.

Discovery & Development Drug Discovery

Can Takeda Help Treat Narcolepsy?

| 5 min read

Research and development in sleep-wake disorders has been asleep on its feet

Discovery & Development Drug Discovery

Addressing the Empire of Pain

| Jamie Irvine | 11 min read

How the pharma industry can help tackle the opioid crisis and advance treatments

Discovery & Development Drug Delivery

The Changing Face of Influenza Vaccination

| Rob Coker

Flu changes, ever so slightly, year by year and region by region. The vaccine manufacturing industry must bring changes of its own.

Discovery & Development Advanced Medicine

Victor Ambros and Gary Ruvkun share 2024 Nobel Prize for Physiology or Medicine

| Rob Coker

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

Discovery & Development Drug Discovery

Biopharmaceuticals: Simplifying Complexity With mRNA

| Gunasekaran Kannan | 7 min read

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

Discovery & Development Dosage Forms

Dosage Form Innovation with Hot Melt Extrusion

| 3 min read

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.

Discovery & Development Drug Discovery

Cell Wars: A New Hope

| Rob Coker

Researchers use AI to reprogram glioblastoma cancer cells

Discovery & Development Formulation

The Liquid Challenge

| Louise Carpenter | 4 min read

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.

Discovery & Development Clinical Trials

Clinical Trials and Digital Doubles

| 5 min read

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register